Related references
Note: Only part of the references are listed.Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
Wanyong Chen et al.
JOURNAL OF CANCER (2018)
Prospero-Related Homeobox 1 Drives Angiogenesis of Hepatocellular Carcinoma Through Selectively Activating Interleukin-8 Expression
Yanfeng Liu et al.
HEPATOLOGY (2017)
Programmed Cell Death-1 (PD-1) Checkpoint Blockade in Combination With a Mammalian Target of Rapamycin Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1
Hui Li et al.
HEPATOLOGY (2017)
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
Thai Huu Ho et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Decreased WWOX expression promotes angiogenesis in osteosarcoma
Jia Wen et al.
ONCOTARGET (2017)
Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk
Hsiang-Lin Lee et al.
PLOS ONE (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
Dario Callegaro et al.
LANCET ONCOLOGY (2016)
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis
Silvio Bandini et al.
ONCOIMMUNOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo
Gang Li et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
WWOX: A fragile tumor suppressor
Morgan S. Schrock et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation
Cyril Mignot et al.
JOURNAL OF MEDICAL GENETICS (2015)
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
Yizhou Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Systematic review of actual 10-year survival following resection for hepatocellular carcinoma
Annelise M. Gluer et al.
HPB (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)
Onur Baykara et al.
TUMOR BIOLOGY (2010)
Targeted Ablation of the WW Domain-Containing Oxidoreductase Tumor Suppressor Leads to Impaired Steroidogenesis
Rami I. Aqeilan et al.
ENDOCRINOLOGY (2009)
Systemic therapy for hepatocellular carcinoma: Cytotoxic chemotherapy, targeted therapy and immunotherapy
Melanie B. Thomas et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX
Ileana Aderca et al.
JOURNAL OF HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin
Robert G. Gish et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Inhibition of breast cancer cell growth in vitro and in vivo: Effect of restoration of Wwox expression
Dimitrios Iliopoulos et al.
CLINICAL CANCER RESEARCH (2007)
Physical association with WWOX suppresses c-Jun transcriptional activity
Eugenio Gaudio et al.
CANCER RESEARCH (2006)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
A role for the WWOX gene in prostate cancer
Haiyan R. Qin et al.
CANCER RESEARCH (2006)
Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer
D Iliopoulos et al.
ONCOGENE (2005)
WWOX:: A candidate tumor suppressor gene involved in multiple tumor types
AJW Paige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Common chromosomal fragile site FRA16D sequence:: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells
K Ried et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
